Recently, WeGene, the leading personal genome company in China, announced the completion of Series B financing. This round of financing was provided by Shell Angel Fund, Chengxin New Life Fund, Huada Gene Group and its venture capital fund Miracle Light, Zhuojia Growth Venture Capital And so on. According to WeGene, the company's direct-to-consumer personal genome service users now exceed 100,000. It is one of the largest genomic data platforms in China and an important platform for promoting research and application of genetic testing.
Has accumulated 100,000 Chinese genetic data to provide users with more accurate services
It is understood that WeGene's genomic data is based on gene chip data, and the gene chip used is customized for the Chinese, providing more than 600,000 sites for detection and analysis services for each user. On this basis, through the bioinformatics technologies such as gene implication, it is possible to accurately obtain detection results of more than 10 million sites. In addition to gene chip data, WeGene has accumulated a large number of Chinese genome-wide sequencing data.
Based on more than 100,000 data cumulants, WeGene has the ability to provide consumers with more accurate data analysis and interpretation services including ancestor analysis, health management, precision nutrition and sports.
More importantly, unlike the general genomic database that was born out of academic research, WeGene is still a direct
The genomic data platform of the fee. In other words, after the user gets the genetic data, in addition to the number of users that WeGene will provide to the user.
In addition to the gene interpretation and analysis services, there are more than ten third-party follow-up service providers that can provide a variety of follow-up services based on the user's genetic data, such as accurate diet, accurate weight management, sports genomics, and genealogy writing. This will greatly promote the development of the entire consumer-grade genetic testing industry, and will greatly reduce the threshold for consumers to enjoy the development of genetic testing technology.
The accumulation of data is the basis of genetic testing and interpretation, and the lack of genomic data in Chinese population has become one of the important obstacles to the research and application of genetic testing technology in China. Not long ago, CCTV announced that China officially launched the "100,000 people's genome project in China", and it took four years to complete the mapping of Chinese people's genetic maps. Since 2015, WeGene has been working on the establishment of a genome database based on the Chinese sample. As of now, the accumulated data has exceeded 100,000 copies. With the launch of WeGene's new multi-million square meters laboratory in Shenzhen and Hong Kong, the WeGene Genome Database is accelerating at a rate of over 10,000 per month, with more than 400,000 genomic data expected by the end of 2018.
Attach importance to scientific research, large-scale database to promote the application of genome research in China
Genetic testing is still an emerging technology, and the regulation of emerging technologies is currently in the process of exploration. In November 2013, the world-renowned genomics company 23andMe was stopped by the FDA, and it is not allowed to provide users with any disease health data analysis other than the ancestral source. However, after more than a year of in-depth research, the FDA finally approved 23andMe to provide Blum syndrome testing services, which means that as research progresses, regulators will gradually relax the scope of application of genetic testing.
While providing personal genome services, WeGene also attaches great importance to genome-related research. It has been cooperating with research institutes such as Shanghai Jiaotong University, Beijing Jishuitan Hospital, Xiamen University, Central South University, Beijing Institute of Genomics of Chinese Academy of Sciences, and Jining Medical College. As the first personal genome service company in China to provide ancestral analysis, in 2017, WeGene team published the first Chinese population genomics research paper based on consumer-level genetic test data in Scientific Reports. In August of the same year, the latest research on the history of the Tibetan Mastiff corridor was published in the top journal of the American Journal of Physical Humanities in the field of biological anthropology.
Under the premise of the user's full knowledge, WeGene will encourage its users to participate in the Chinese genome-related research projects carried out by domestic research institutions in a variety of ways. Such a large-scale genomic database will greatly promote our country's genome research. As we have a deeper understanding of the Chinese genome, genetic testing, gene therapy and other genetic science methods are becoming more and more mature, and genetic information will become an important reference factor for medical research, clinical diagnosis and disease treatment. (Northeast News Network)
Sandy Finish PVC Coated Gloves
Sandy Finish Pvc Gloves,Pvc Supported Hand Gloves,Green Pvc Dipped Gloves,12Inch Pvc Gloves
JINAN SHANDE SECURITY TECHNOLOGY CO., LTD , https://www.sdsxlb.com